Aaron I. Davis Odonate Therapeutics, Inc. (ODTC) insider trading activity

ODTC Quotes by TradingView

Aaron I. Davis is Director of Odonate Therapeutics, Inc.. Currently has a direct ownership of 445,756 shares of ODTC, which is worth approximately $7.6 Billion. The most recent transaction as insider was on Nov 19, 2021, when has been sold 30,000 shares (Common Stock) at a price of $1.92 per share, resulting in proceeds of $57,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 446K
0% 3M change
0% 12M change
Total Value Held $7.6 Billion

Aaron I. Davis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
SELL
Open market or private sale
$57,600 $1.92 p/Share
30,000 Reduced 6.31%
445,756 Common Stock
Nov 17 2021
SELL
Open market or private sale
$379,100 $2.23 p/Share
170,000 Reduced 26.33%
475,756 Common Stock

Also insider at

MRTX
Mirati Therapeutics, Inc. Healthcare
RAIN
Rain Therapeutics Inc. Healthcare
Director
ITOS
iTeos Therapeutics, Inc. Healthcare
TNGX
Tango Therapeutics, Inc. Healthcare
Director
AID

Aaron I. Davis

Director
Newark, CA

Track Institutional and Insider Activities on ODTC

Follow Odonate Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ODTC shares.

Notify only if

Insider Trading

Get notified when an Odonate Therapeutics, Inc. insider buys or sells ODTC shares.

Notify only if

News

Receive news related to Odonate Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ODTC